- 首頁
- App 分析
- Diabetes CVD Risk Score
- Diabetes CVD Risk Score Vs. EuroSCORE II
Diabetes CVD Risk Score 與 EuroSCORE II 使用情況與統計
The Diabetes Cardiovascular Disease (CVD) risk score tool was developed as a simple method to illustrate the risk of developing a major adverse cardiovascular event (MACE) amongst type 2 diabetes patients at high cardiovascular risk. The Diabetes CVD Risk Score tool is based on actual data from the LEADER trial, a cardiovascular outcomes trial. In the LEADER trial, MACE was the composite primary outcome and defined as time to first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke.
By adjusting the 11 CVD risk factors in the app (age, HbA1c, diabetes duration, BMI, systolic blood pressure, sex, insulin use, history of heart failure, history of myocardial infarction or stroke, renal disease status and smoking status), the Diabetes CVD risk score tool displays a patient’s risk in percent of experiencing a MACE within a time frame of 3 years.
The purpose of the Diabetes CVD risk score tool is to illustrate the risk of MACE within a patient population with the same characteristics. The tool cannot be used to provide a “true” risk estimate for an individual patient. As such, the tool is solely for information purposes, not for diagnosis or treatment purposes, and should not be relied on as the basis for any decision or action.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
EuroSCORE stands for European System for Cardiac Operative Risk Evaluation. It identifies a number of risk factors which help to predict mortality from cardiac surgery. The original EuroSCORE calculator was published in 1999, derived from an international database of patients undergoing cardiac surgery. The EuroSCORE II calculator was released for use on October 3, 2011 at the European Association of Cardiothoracic Surgery meeting in Lisbon.
The original calculator is used worldwide for both the measurement of risk and as a benchmark for the assessment of quality of cardiac surgical services. There are more than 1300 formal citations of the EuroSCORE in the medical literature.
The previous additive and logistic EuroSCORE versions are now inappropriately calibrated but have remained powerfully discriminatory. Nevertheless, there is evidence that discrimination may be improved further by refining and modifying some of the risk factors, such as renal dysfunction. Therefore, the new EuroSCORE II calculator was developed to optimize its useful application in contemporary practice.
The EuroSCORE II calculator is to be used as an educational tool only, and it should not be viewed as a substitute for the opinion of expert Cardiac Surgeons and Cardiologists. Clinical judgement must be used whenever rare risk factors are present. The risk model provides a set standard, and units and surgeons will perform at, above or below the standard. Best practice in quoting risk to patients is to adjust the risk calculated by EuroSCORE II to the results achieved by the unit in question. The application is meant to be used as a tool to guide discussions with patients, families, and healthcare providers regarding the potential outcomes after open heart surgery.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
Diabetes CVD Risk Score與 EuroSCORE II 比較排名
比較過去 28 天的 Diabetes CVD Risk Score 排名趨勢與 EuroSCORE II
排名
無可用數據
各國 Diabetes CVD Risk Score vs. EuroSCORE II 排名比較
比較過去 28 天的 Diabetes CVD Risk Score 排名趨勢與 EuroSCORE II
無可顯示數據
使用我們的免費試用版,與所有網站進行比較
Diabetes CVD Risk Score VS.
EuroSCORE II
1月 3, 2025